Increased auditory startle response and reduced prepulse inhibition of startle in transgenic mice expressing a double mutant form of amyloid precursor protein

Brain Research

Volumn 994, Issue 1, 2003, Pages 99-106

  McCool, Martha F ^a   Varty, Geoffrey B ^a   Del Vecchio, Robert A ^a   Kazdoba, Tatiana M ^a   Parker, Eric M ^a   Hunter, John C ^a   Hyde, Lynn A ^a  

^a MERCK RESEARCH LABORATORIES   (United States)

Author keywords

Alzheimer's disease; Amyloid precursor protein; Auditory startle; Behavior; CRND8 transgenic mice; Prepulse inhibition; Sensorimotor gating

Indexed keywords

AMYLOID PRECURSOR PROTEIN; MUTANT PROTEIN;

AGE DISTRIBUTION; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AUDITORY STIMULATION; CONTROLLED STUDY; FEMALE; GENOTYPE; IMMUNOHISTOCHEMISTRY; MALE; MOUSE; MOUSE STRAIN; NEUROPATHOLOGY; NONHUMAN; PREPULSE INHIBITION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INDUCTION; SENSORIMOTOR FUNCTION; STARTLE REFLEX; TRANSGENIC MOUSE;

EID: 0344875100     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainres.2003.09.025     Document Type: Article

References (16)

1. Braff D.L., Stone C., Callaway E., Geyer M.A., Glick I., Bali L. Prestimulus effects on human startle reflex in normals and schizophrenics. Psychophysiology. 15:1978;339-343.
2. Carter R.J., Lione L.A., Humby T., Mangiarini L., Mahal A., Bates G.P., Dunnett S.B., Morton A.J. Characterization of progressive motor deficits in mice transgenic for the human Huntington's disease mutation. J. Neurosci. 19:1999;3248-3257.
3. Chishti M.A., Yang D.S., Janus C., Phinney A.L., Horne P., Pearson J., Strome R., Zuker N., Loukides J., French J., Turner S., Lozza G., Grilli M., Kunicki S., Morissette C., Paquett J., Gervais F., Bergeron C., Fraser P.E., Carlson G.A., St. George-Hyslop P.D., Westaway D. Early-onset amyloid deposition and cognitive deficits in transgenic mice expressing a double mutant form of amyloid precursor protein 695. J. Biol. Chem. 276:2001;21562-21570.
4. Diez M., Koistinaho J., Kahn K., Games D., Hokfelt T. Neuropeptides in hippocampus and cortex in transgenic mice overexpressing V717F β-amyloid precursor protein-initial observations. Neuroscience. 100:2000;259-286.
5. Dirks A., Groenink L., Schipholt M.I., van der Gugten J., Hijzen T.H., Geyer M.A., Olivier B. Reduced startle reactivity and plasticity in transgenic mice overexpressing corticotrophin-releasing hormone. Biol. Psychiatry. 51:2002;583-590.
6. Geyer M.A., Wilkinson L.S., Humby T., Robbins T.W. Isolation rearing of rats produces a deficit in prepulse inhibition of acoustic startle similar to that in schizophrenia. Biol. Psychiatry. 34:1993;361-372.
7. Geyer M.A., McIlwain K.L., Paylor R. Mouse genetic models for prepulse inhibition: an early review. Mol. Psychiatry. 7:2002;1039-1053.
8. Grillon C., Ameli R., Charney D.S., Krystal J., Braff D. Startle gating deficits occur across prepulse intensities in schizophrenic patients. Biol. Psychiatry. 32:1992;939-943.
9. Hartman R.E., Wozniak D.F., Nardi A., Olney J.W., Sartorius L., Holtzman D.M. Behavioral phenotyping of GFAP-ApoE3 and -ApoE4 transgenic mice: ApoE4 mice show profound working memory impairments in the absence of Alzheimer's-like neuropathology. Exp. Neurol. 170:2001;326-344.
10. Janus C., Pearson J., McLaurin J., Mathews P.M., Jiang Y., Schmidt S.D., Chishti M.A., Horne P., Heslin D., French J., Mount H.T.J., Nixon R.A., Mercken M., Bergeron C., Fraser P.E., St. George-Hyslop P., Westaway D. Aβ peptide immunization reduces behavioral impairment and plaques in a model of Alzheimer's disease. Nature. 408:2000;979-982.
11. Jessen F., Kucharski C., Fries T., Papassotiropoulos A., Hoenig K., Maier W., Heun R. Sensory gating deficit expressed by a disturbed suppression of the P50 event-related potential in patients with Alzheimer's disease. Am. J. Psychiatry. 158:2001;1319-1321.
12. Jeste D.V., Wragg R.E., Salmon D.P., Harris M.J., Thal L.J. Cognitive deficits of patients with Alzheimer's disease with and without delusions. Am. J. Psychiatry. 149:1992;184-189.
13. Mansbach R.S. Effects of NMDA receptor ligands on sensorimotor gating in the rat. Eur. J. Pharmacol. 202:1991;61-66.
14. Mansbach R.S., Geyer M.A., Braff D.L. Dopaminergic stimulation disrupts sensorimotor gating in the rat. Psychopharmacology. 94:1988;507-514.
15. Sipes T.A., Geyer M.A. Multiple serotonin receptor subtypes modulate prepulse inhibition of the startle response in rats. Neuropharmacology. 33:1994;441-448.
16. Swerdlow N.R., Braff D.L., Geyer M.A. Animal models of deficient sensorimotor gating: what we know, what we think we know, and what we hope to know soon. Behav. Pharmacol. 11:2000;185-204.